# ABBOTT LABORATORIES (ABT) FY2024 YTD Q3 P&L / Income Statement

- Company: ABBOTT LABORATORIES (ABT)
- Period: 2024-01-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-31, accession number 0001628280-24-044602
- Page: https://plicit.ai/financials/abt/fy2024-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/abt-fy2024-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2024-01-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 30,976,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 13,764,000,000 US dollars
- **Gross profit (calculated)**: 17,212,000,000 US dollars
- **Operating expenses (calculated)**: 12,298,000,000 US dollars
- **Operating earnings**: 4,914,000,000 US dollars
- **Other income (expense), net (calculated)**: 69,000,000 US dollars
- **Earnings before taxes**: 4,983,000,000 US dollars
- **Taxes on earnings**: 810,000,000 US dollars
- **Net Earnings**: 4,173,000,000 US dollars
- **Established Pharmaceutical Products**: 3,926,000,000 US dollars
- **Nutritional Products**: 6,284,000,000 US dollars
- **Diagnostic Products**: 6,821,000,000 US dollars
- **Medical Devices**: 13,934,000,000 US dollars
- **Amortization of intangible assets**: 1,413,000,000 US dollars
- **Research and development**: 2,095,000,000 US dollars
- **Selling, general and administrative**: 8,790,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 30,965,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Other**: 11,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Established Pharmaceutical Products costs (calculated)**: 2,964,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Nutritional Products costs (calculated)**: 5,222,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Diagnostic Products costs (calculated)**: 5,359,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Medical Devices costs (calculated)**: 9,554,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 2,963,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/abt/fy2024-ytd-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/abt-fy2024-ytd-q3-revenue-by-geography-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 30,976,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 13,764,000,000 US dollars
- **Gross profit (calculated)**: 17,212,000,000 US dollars
- **Operating expenses (calculated)**: 12,298,000,000 US dollars
- **Operating earnings**: 4,914,000,000 US dollars
- **Other income (expense), net (calculated)**: 69,000,000 US dollars
- **Earnings before taxes**: 4,983,000,000 US dollars
- **Taxes on earnings**: 810,000,000 US dollars
- **Net Earnings**: 4,173,000,000 US dollars
- **UNITED STATES**: 11,982,000,000 US dollars
- **International**: 18,994,000,000 US dollars
- **Amortization of intangible assets**: 1,413,000,000 US dollars
- **Research and development**: 2,095,000,000 US dollars
- **Selling, general and administrative**: 8,790,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.